Niloufar Salehi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Editorial Comment

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Niloufar Salehi, Jozef Al-Gousous, Bart Hens, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation. Molecular pharmaceutics 21 (5) (2024)
Niloufar Salehi, Jozef Al-Gousous, Bart Hens, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation. Molecular pharmaceutics (2024)
Patrick D Sinko, Niloufar Salehi, Troy Halseth, Pamela J Meyer, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer. Molecular pharmaceutics 21 (1) (2023)
Niloufar Salehi
Voices in Molecular Pharmaceutics : Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models. Molecular pharmaceutics (2023)
Patrick D Sinko, Niloufar Salehi, Troy Halseth, Pamela J Meyer, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer. Molecular pharmaceutics 21 (1) (2023)
Patrick D Sinko, Niloufar Salehi, Troy Halseth, Pamela J Meyer, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary Layer. Molecular pharmaceutics (2023)
Gislaine Kuminek, Niloufar Salehi, Nicholas M Waltz, David C Sperry, Dale E Greenwood, Siddhi S Hate, Gregory E Amidon
Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study. Molecular pharmaceutics (2022)
Niloufar Salehi, Gislaine Kuminek, Jozef Al-Gousous, David C Sperry, Dale E Greenwood, Nicholas M Waltz, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis. Molecular pharmaceutics 18 (9) (2021)
Niloufar Salehi, Jozef Al-Gousous, Deanna M Mudie, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel. Molecular pharmaceutics 17 (10) (2020)